These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17689338)

  • 1. Drug consumption rooms: an overdue extension to harm reduction policy in the UK?
    Lloyd C; Hunt N
    Int J Drug Policy; 2007 Jan; 18(1):5-9. PubMed ID: 17689338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilizing Drug Consumption Rooms: inter-place networks and harm reduction drug policy.
    McCann E; Temenos C
    Health Place; 2015 Jan; 31():216-23. PubMed ID: 25576837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'We are still obsessed by this idea of abstinence': A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow, UK.
    Atkinson AM; McAuley A; Trayner KMA; Sumnall HR
    Int J Drug Policy; 2019 Jun; 68():62-74. PubMed ID: 31003193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 5. Public perceptions of public drug use in four UK urban sites.
    Cusick L; Kimber J
    Int J Drug Policy; 2007 Jan; 18(1):10-7. PubMed ID: 17689339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs.
    Kappel N; Toth E; Tegner J; Lauridsen S
    Harm Reduct J; 2016 Jun; 13(1):20. PubMed ID: 27306441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms.
    Toth EC; Tegner J; Lauridsen S; Kappel N
    Harm Reduct J; 2016 Oct; 13(1):27. PubMed ID: 27717366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug consumption rooms: Comparing times, spaces and actors in issues of social acceptability in French public debate.
    Jauffret-Roustide M; Cailbault I
    Int J Drug Policy; 2018 Jun; 56():208-217. PubMed ID: 29754895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis and drug consumption rooms, a French impasse].
    Nau JY
    Rev Med Suisse; 2012 Oct; 8(360):2098-9. PubMed ID: 23185933
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of messaging on public support for drug consumption rooms in scotland, UK.
    Sumnall HR; Atkinson AM; Trayner KMA; Gage SH; McAuley A
    Int J Drug Policy; 2020 Sep; 83():102855. PubMed ID: 32693322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Consumption Rooms and Public Health Policy: Perspectives of Scottish Strategic Decision-Makers.
    Nicholls J; Livingston W; Perkins A; Cairns B; Foster R; Trayner KMA; Sumnall HR; Price T; Cairney P; Dumbrell J; Parkes T
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Governance versus government: drug consumption rooms in Australia and the UK.
    Zampini GF
    Int J Drug Policy; 2014 Sep; 25(5):978-84. PubMed ID: 24746642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact.
    Kimber J; Dolan K; Wodak A
    Drug Alcohol Rev; 2005 Jan; 24(1):21-4. PubMed ID: 16191717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation.
    Smith P; Favril L; Delhauteur D; Vander Laenen F; Nicaise P
    Addict Sci Clin Pract; 2019 Nov; 14(1):40. PubMed ID: 31672169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.